title: Inhibition of (-)-propranolol hydrochloride by its enantiomer in white mice.
abstract: BACKGROUND
  This study is based on the hypothesis, that the toxic or physiological effects of an optical isomer may be counteracted or reversed by the administration of a potentized preparation of one of its stereoisomers. In the present study the enantiomer was used.
  
  
  METHODS
  154 ICR conventional mice were used. 77 mice were administered (R)-(+)-propranolol HCl homeopathic potency prior to and during the experiment, and the other 77 were administered indistinguishable placebo. On the day of the experiment the mice were sedated with intraperitoneal Rometar. Once sedated they were injected intraperitoneally with the LD50 dose of (S)-(-)-propranolol HCl.
  
  
  RESULTS
  The end point for statistical analysis was the difference in survival between the placebo and treatment mice. The odds ratio for survival of treatment mice relative to placebo mice was 1.64. The hypothesis of equal survival proportions gave a chi-square of 2.0916 (1 degree of freedom), which has a p-value of 0.1481. The analysis was then adjusted for mouse weight and intraperitoneal (-)-propranolol dosage using a logistic regression (LR) model. The LR treatment odds ratio was 2.017 and the LR treatment chi-square was 2.8864 (1 degree of freedom), which has a p-value of 0.0893. Consequently we accept the null hypothesis of no treatment effect on survival. The odds ratio estimates show that the treatment mice are 2.02 times more likely to survive than placebo mice, but this was not statistically significant with p = 0.089. Nine percent more treatment mice survived than placebo mice. The investigators accustomed to handling rodents noted that mouse recovery seemed substantially faster in the treatment mice than in the placebo mice.
authors.affiliation: Graduate School of Integrative Medicine, Swinburne University of Technology, Melbourne, Victoria, Australia. kuzeffm@ausdoctors.net
authors.forename: R M
authors.initials: RM
authors.lastname: Kuzeff
authors.forename: M N
authors.initials: MN
authors.lastname: Topashka-Ancheva
authors.forename: R P
authors.initials: RP
authors.lastname: Mecheva
mesh_terms: D000818:Animals; D005260:Female; D007274:Injections, Intraperitoneal / Q000662:veterinary; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D016017:Odds Ratio; D011433:Propranolol / Q000037:antagonists & inhibitors*; D011897:Random Allocation; D013237:Stereoisomerism; D014665:Vasodilator Agents / Q000037:antagonists & inhibitors*
chemical_list: D014665:Vasodilator Agents; D011433:Propranolol